Lazard Asset Management »

Haemonetics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Haemonetics shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Haemonetics

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.0M 7.5M 0.93
2024-06-30 $6.8M 7.5M 0.90
2024-03-31 $2.1M 2.3M 0.92

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Amazon.com Common Stock (AMZN)
Apple Common Stock (AAPL)
Alphabet Inc A Common Stock (GOOGL)
Intercontinen Common Stock (ICE)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Unitedhealth Gr Common Stock (UNH)
Accenture Common Stock (ACN)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Exelon Corp Common Stock (EXC)
Aon Plc/ireland Common Stock (AON)
Exxon Mobil Common Stock (XOM)
Broadcom Common Stock (AVGO)

View all positions for Lazard Asset Management

Top funds holding Haemonetics

Tenor Capital Management
Franklin Resources
MacKay Shields
Aviva
Osterweis Capital Management
Readystate Asset Management
Braidwell
Wells Fargo & Company
Lazard Asset Management
Oaktree Capital Management
State Street Corporation
Kohlberg Kravis Roberts & Co
SSI Investment Management
Bnp Paribas Investment Partners
BlackRock

View all funds holding Haemonetics